Moran Wealth Management LLC Purchases 341 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Moran Wealth Management LLC lifted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 24.2% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,749 shares of the medical equipment provider’s stock after acquiring an additional 341 shares during the quarter. Moran Wealth Management LLC’s holdings in Intuitive Surgical were worth $859,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in ISRG. International Assets Investment Management LLC lifted its position in shares of Intuitive Surgical by 49,383.6% in the 3rd quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider’s stock worth $535,788,000 after purchasing an additional 1,088,415 shares during the period. Strategic Financial Concepts LLC lifted its holdings in Intuitive Surgical by 40,221.4% during the second quarter. Strategic Financial Concepts LLC now owns 266,121 shares of the medical equipment provider’s stock worth $1,184,000 after buying an additional 265,461 shares during the period. Manning & Napier Advisors LLC bought a new stake in Intuitive Surgical during the 2nd quarter valued at $91,466,000. Assenagon Asset Management S.A. increased its holdings in shares of Intuitive Surgical by 15.4% in the 2nd quarter. Assenagon Asset Management S.A. now owns 1,483,406 shares of the medical equipment provider’s stock valued at $659,893,000 after acquiring an additional 197,841 shares during the period. Finally, Swedbank AB bought a new position in shares of Intuitive Surgical in the 1st quarter worth $74,379,000. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG opened at $550.43 on Friday. The stock’s 50-day moving average is $503.57 and its two-hundred day moving average is $461.88. The company has a market cap of $196.05 billion, a price-to-earnings ratio of 88.49, a price-to-earnings-growth ratio of 5.30 and a beta of 1.39. Intuitive Surgical, Inc. has a 1-year low of $304.50 and a 1-year high of $551.78.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, beating the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The business had revenue of $2.04 billion during the quarter, compared to the consensus estimate of $2.01 billion. Equities research analysts anticipate that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on ISRG shares. Citigroup raised their price objective on Intuitive Surgical from $512.00 to $560.00 and gave the company a “buy” rating in a research report on Thursday, August 22nd. Evercore ISI restated a “cautious” rating on shares of Intuitive Surgical in a report on Friday, October 18th. Stifel Nicolaus boosted their price objective on shares of Intuitive Surgical from $475.00 to $525.00 and gave the stock a “buy” rating in a research note on Friday, October 18th. Oppenheimer restated a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Finally, Leerink Partners upped their price target on Intuitive Surgical from $489.00 to $502.00 in a research report on Thursday, October 17th. One analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have issued a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $524.61.

Insider Transactions at Intuitive Surgical

In other news, EVP Robert Desantis sold 396 shares of Intuitive Surgical stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $486.88, for a total value of $192,804.48. Following the sale, the executive vice president now owns 5,506 shares of the company’s stock, valued at $2,680,761.28. The trade was a 6.71 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Jamie Samath sold 269 shares of Intuitive Surgical stock in a transaction that occurred on Monday, November 11th. The shares were sold at an average price of $539.89, for a total value of $145,230.41. Following the completion of the sale, the insider now directly owns 8,757 shares in the company, valued at $4,727,816.73. This represents a 2.98 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 50,935 shares of company stock worth $26,305,169. Company insiders own 0.90% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.